---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-164461"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:23:18.949843+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Viridian shareholders approve 2M share increase for equity plan; directors elected

## Summary
- Amendment to 2016 equity plan approved (32.2M for, 24.3M against), adding 2M shares to reserve.
- Class III directors Stephen Mahoney and Arlene M. Morris elected; Morris received 24.9M withheld votes.
- Advisory vote on exec compensation passed: 32.8M for, 23.7M against.
- Ratification of KPMG as independent auditor passed: 58.4M for, 31.7K against.

## SEC filing metadata
- accession: 0001193125-24-164461
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/0001193125-24-164461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/d857947d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-164461
- JSON: https://secwatch.observer/filing/0001193125-24-164461.json
- Plain text: https://secwatch.observer/filing/0001193125-24-164461.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.